EUVIMEDEUVIMED entdecken
Crossref

Risk of malignancy for biliary cytology based on World Health Organization (WHO) reporting system for pancreaticobiliary cytopathology

Annie Elizabeth Abraham, Xinjun Wang, Imani Hargett, Zaynab Pharaa, Camille Sears, Mithat Gonen, Rajmohan Murali iD, Oscar Lin iD, Alice Wei, Adrian Gonzalez-Aguirre, Pari Shah, Carlie Sigel iD

Cancer Cytopathology · 2026-06 · 134 (6)

DOI: 10.1002/cncy.70109 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Cytopathology, online erschienen am 16.05.2026. Verfasst von Annie Elizabeth Abraham und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA. Hauptthemen laut MEDLINE: Cytodiagnosis, Pancreatic Neoplasms, Bile Duct Neoplasms, Biliary Tract Neoplasms. Die Arbeit nennt 16 Literaturangaben. Gefördert von: Marie-Josée and Henry R. Kravis Center for Molecular Oncology, the Cancer Center Support Grant of the National Institutes of Health/National Cancer Institute u…, NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The World Health Organization (WHO) classification for pancreaticobiliary cytopathology stratifies risk of malignancy (ROM) and outcome for pancreatic fine‐needle aspirations (FNAs). ROM for biliary cytology, particularly for WHO categories Pan‐low (IV) and Pan‐high (V), has not been well examined.

Methods

Retrospective data of biliary cytology diagnosed from 2016 to 2019 were collected. WHO classification was assigned. Malignant outcome was determined by histologic correlation or clinical progression/death. Excluding clinical follow‐up

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CytodiagnosisPancreatic NeoplasmsBile Duct NeoplasmsBiliary Tract NeoplasmsHumansWorld Health OrganizationFemaleRetrospective StudiesMaleMiddle AgedAgedBiopsy, Fine-NeedleAdultAged, 80 and over

Stichwörter der Autor:innen

FNAWorld Health Organizationbile ductbile duct brushingbiliary brushingcytopathologypancreaticobiliaryrisk of malignancy

Autor:innen und Institutionen

  • Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.

ORCID-Profile: Rajmohan Murali, Oscar Lin, Carlie Sigel

Förderung

  • Marie-Josée and Henry R. Kravis Center for Molecular Oncology, the Cancer Center Support Grant of the National Institutes of Health/National Cancer Institute u…
  • NCI NIH HHS

Zitieren

APA

Abraham, A. E., Wang, X., Hargett, I., Pharaa, Z., Sears, C., Gonen, M., Murali, R., Lin, O., Wei, A., Gonzalez-Aguirre, A., Shah, P., & Sigel, C. (2026). Risk of malignancy for biliary cytology based on World Health Organization (WHO) reporting system for pancreaticobiliary cytopathology. Cancer Cytopathology, 134(6). https://doi.org/10.1002/cncy.70109

Vancouver

Abraham AE, Wang X, Hargett I, Pharaa Z, Sears C, Gonen M, et al. Risk of malignancy for biliary cytology based on World Health Organization (WHO) reporting system for pancreaticobiliary cytopathology. Cancer Cytopathology. 2026;134(6). doi:10.1002/cncy.70109

BibTeX
@article{Abraham2026,
  author = {Abraham, Annie Elizabeth and Wang, Xinjun and Hargett, Imani and Pharaa, Zaynab and Sears, Camille and Gonen, Mithat and Murali, Rajmohan and Lin, Oscar and Wei, Alice and Gonzalez-Aguirre, Adrian and Shah, Pari and Sigel, Carlie},
  title = {Risk of malignancy for biliary cytology based on World Health Organization (WHO) reporting system for pancreaticobiliary cytopathology},
  journal = {Cancer Cytopathology},
  year = {2026},
  volume = {134},
  number = {6},
  doi = {10.1002/cncy.70109}
}
Kostenlos starten →